110 related articles for article (PubMed ID: 9155539)
1. Trofosfamide as a salvage treatment with low toxicity in malignant lymphoma. A phase II study.
Helsing MD
Eur J Cancer; 1997 Mar; 33(3):500-2. PubMed ID: 9155539
[TBL] [Abstract][Full Text] [Related]
2. Trofosfamide in non-Hodgkin's lymphoma. A phase II study.
Wist E; Risberg T
Acta Oncol; 1991; 30(7):819-21. PubMed ID: 1764273
[TBL] [Abstract][Full Text] [Related]
3. Palliative chemotherapy in non-Hodgkin's lymphoma.
Salminen E; Nikkanen V; Lindholm L
Oncology; 1997; 54(2):108-11. PubMed ID: 9075780
[TBL] [Abstract][Full Text] [Related]
4. Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.
Witte HM; Riecke A; Mayer T; Bartscht T; Rades D; Lehnert H; Merz H; Fetscher S; Biersack H; Gebauer N
J Cancer Res Clin Oncol; 2019 Jan; 145(1):129-136. PubMed ID: 30327940
[TBL] [Abstract][Full Text] [Related]
5. Trofosfamide as salvage therapy for anaplastic large cell lymphoma relapsing after high-dose chemotherapy.
Andersson PO; Braide I; Nilsson-Ehle H
Leuk Lymphoma; 2002 Dec; 43(12):2351-3. PubMed ID: 12613523
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.
Hartmann JT; Oechsle K; Mayer F; Kanz L; Bokemeyer C
Anticancer Res; 2003; 23(2C):1899-901. PubMed ID: 12820475
[TBL] [Abstract][Full Text] [Related]
7. Salvage chemotherapy using a combination of fludarabine and cyclophosphamide for refractory or relapsing indolent and aggressive non-Hodgkin's lymphomas.
Lossos IS; Paltiel O; Polliack A
Leuk Lymphoma; 1999 Mar; 33(1-2):155-60. PubMed ID: 10194133
[TBL] [Abstract][Full Text] [Related]
8. Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphoma.
Robak T; Lech-Maranda E; Janus A; Blonski J; Wierzbowska A; Gora-Tybor J
Leuk Lymphoma; 2007 Jun; 48(6):1092-101. PubMed ID: 17577772
[TBL] [Abstract][Full Text] [Related]
9. [Ixoten therapy in malignant lymphomas].
Pötzi P; Aiginger P; Kühböck J
Acta Med Austriaca; 1979; 6(5):247-9. PubMed ID: 400215
[TBL] [Abstract][Full Text] [Related]
10. Complete remission after repeated trofosfamide treatment in relapsing high-grade malignant non-Hodgkin's lymphoma--a case report.
Norum J
Acta Oncol; 1994; 33(7):831. PubMed ID: 7993654
[No Abstract] [Full Text] [Related]
11. Oral cyclophosphamide therapy for patients with residual or relapsed indolent-type lymphoma after initial treatment for aggressive lymphomas. A sub-group of patients with apparent transformed indolent lymphoma.
Riccioni R; Galimberti S; Cervetti G; Fazzi R; Caracciolo F; Petrini M
Leuk Lymphoma; 2002 Sep; 43(9):1803-6. PubMed ID: 12685835
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced refractory lymphomas with a combination of carmustine, bleomycin, teniposide, dexamethasone, and cisplatin (the BBVDD regimen). An ECOG pilot study.
Spiers AS; Weens JH; Rowe JM; Smith TJ; Horton J; Gordon LI; Glick JH
Am J Clin Oncol; 1991 Dec; 14(6):519-25. PubMed ID: 1720279
[TBL] [Abstract][Full Text] [Related]
13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
14. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
Bremer K
J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
Zinzani PL; Barbieri E; Visani G; Gherlinzoni F; Perini F; Neri S; Bendandi M; Ammendolia I; Salvucci M; Babini L
Haematologica; 1994; 79(6):508-12. PubMed ID: 7534744
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma.
Kollmannsberger C; Brugger W; Hartmann JT; Maurer F; Böhm P; Kanz L; Bokemeyer C
Anticancer Drugs; 1999 Jun; 10(5):453-6. PubMed ID: 10477164
[TBL] [Abstract][Full Text] [Related]
17. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide or trofosfamide in patients with intraocular lymphoma.
Jahnke K; Thiel E; Bechrakis NE; Willerding G; Kraemer DF; Fischer L; Korfel A
J Neurooncol; 2009 Jun; 93(2):213-7. PubMed ID: 19099202
[TBL] [Abstract][Full Text] [Related]
20. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
